Clinical Trial Update: The Efficacy and Safety of Sonrotoclax, Zanubrutinib Combined With Obinutuzumab in MCL [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the combination of Sonrotoclax, Zanubrutinib, and Obinutuzumab in intermediate-to-high-risk Mantle Cell Lymphoma, focusing on efficac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mantle Cell Lymphoma

Drugs mentioned

• Obinutuzumab (obinutuzumab)
• Sonrotoclax
• Zanubrutinib (zanubrutinib)

Snippet

Sponsor: Ruijin Hospital | Conditions: Intermediate-to-High-Risk Mantle Cell Lymphoma, the Efficacy and Safety | Phase 1 | Status: NOT_YET_RECRUITING